Crossmark

HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1186/s13046-021-02188-y

Published Online: 2021-12-20

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Yiwei

Chen, Zhencong

Lu, Tao

Bi, Guoshu

Li, Ming

Liang, Jiaqi

Hu, Zhengyang

Zheng, Yuansheng

Yin, Jiacheng

Xi, Junjie

Lin, Zongwu

Zhan, Cheng https://orcid.org/0000-0001-8745-9276
Jiang, Wei

Wang, Qun

Tan, Lijie
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-20
More Information

Article History

Received: 27 July 2021

Accepted: 19 November 2021

First Online: 20 December 2021

Declarations

:

: All animals received standard care, and animal procedures were approved by the Institutional Review Committee of Zhongshan Hospital, Fudan University (Shanghai, China) (approval number: IBCB-SPF1314). The Institutional Review Committee of Zhongshan Hospital, Fudan University (Shanghai, China) approved the use of the clinical information and human tissue samples in this study (approval number: IBCB-0213).

: All authors agree to publish.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below